News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
845,315 Results
Type
Article (86425)
Company Profile (702)
Press Release (758188)
Multimedia
Podcasts (128)
Webinars (14)
Section
Business (232646)
Career Advice (4126)
Deals (39715)
Drug Delivery (129)
Drug Development (90970)
Employer Resources (198)
FDA (18095)
Job Trends (17328)
News (396395)
Policy (39737)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (13)
2025 Lone Star Bio Digital (16)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (91)
Alliances (56815)
ALS (98)
Alzheimer's disease (1496)
Antibody-drug conjugate (ADC) (154)
Approvals (18060)
Artificial intelligence (318)
Autoimmune disease (29)
Automation (16)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (481)
Bladder cancer (72)
Brain cancer (31)
Breast cancer (296)
Cancer (2325)
Cardiovascular disease (200)
Career advice (3532)
Career pathing (34)
CAR-T (166)
Cell therapy (471)
Cervical cancer (21)
Clinical research (73308)
Collaboration (891)
Compensation (538)
Complete response letters (30)
COVID-19 (2862)
CRISPR (45)
C-suite (255)
Cystic fibrosis (107)
Data (2157)
Decentralized trials (2)
Denatured (45)
Depression (54)
Diabetes (291)
Diagnostics (6908)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (152)
Drug pricing (125)
Drug shortages (33)
Duchenne muscular dystrophy (100)
Earnings (96459)
Editorial (43)
Employer branding (25)
Employer resources (167)
Events (129658)
Executive appointments (754)
FDA (19380)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (808)
Gene editing (115)
Generative AI (35)
Gene therapy (341)
GLP-1 (848)
Government (5154)
Grass and pollen (6)
Guidances (52)
Healthcare (20883)
Huntington's disease (25)
IgA nephropathy (28)
Immunology and inflammation (142)
Indications (29)
Infectious disease (3023)
Inflammatory bowel disease (150)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (97)
Interviews (812)
IPO (17807)
IRA (51)
Job creations (5186)
Job search strategy (2861)
Kidney cancer (11)
Labor market (42)
Layoffs (549)
Leadership (22)
Legal (10113)
Liver cancer (78)
Lung cancer (335)
Lymphoma (152)
Machine learning (6)
Management (65)
Manufacturing (343)
MASH (73)
Medical device (14618)
Medtech (14623)
Mergers & acquisitions (22431)
Metabolic disorders (774)
Multiple sclerosis (84)
NASH (23)
Neurodegenerative disease (109)
Neuropsychiatric disorders (34)
Neuroscience (2082)
NextGen: Class of 2025 (7682)
Non-profit (5078)
Northern California (2660)
Now hiring (40)
Obesity (419)
Opinion (274)
Ovarian cancer (76)
Pain (93)
Pancreatic cancer (84)
Parkinson's disease (159)
Partnered (24)
Patents (244)
Patient recruitment (109)
Peanut (51)
People (65240)
Pharmaceutical (143)
Pharmacy benefit managers (21)
Phase I (22611)
Phase II (31824)
Phase III (23992)
Pipeline (1190)
Policy (166)
Postmarket research (3552)
Preclinical (10160)
Press Release (72)
Prostate cancer (105)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (423)
Real estate (7391)
Recruiting (75)
Regulatory (26744)
Reports (57)
Research institute (2657)
Resumes & cover letters (649)
Rett syndrome (4)
RNA editing (4)
RSV (50)
Schizophrenia (78)
Series A (141)
Series B (89)
Service/supplier (30)
Sickle cell disease (58)
Southern California (2307)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4290)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (37)
The Weekly (81)
United States (24059)
Vaccines (798)
Venture capitalists (44)
Weight loss (301)
Women's health (40)
Worklife (19)
Date
Today (161)
Last 7 days (648)
Last 30 days (2649)
Last 365 days (35833)
2025 (10854)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (59)
Alaska (7)
Arizona (267)
Arkansas (14)
Asia (50085)
Australia (8824)
California (6223)
Canada (2012)
China (542)
Colorado (278)
Connecticut (293)
Delaware (150)
Europe (114828)
Florida (907)
Georgia (216)
Hawaii (1)
Idaho (64)
Illinois (612)
India (31)
Indiana (330)
Iowa (11)
Japan (164)
Kansas (109)
Kentucky (27)
Louisiana (14)
Maine (70)
Maryland (943)
Massachusetts (4782)
Michigan (243)
Minnesota (414)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (62)
New Hampshire (69)
New Jersey (1768)
New Mexico (31)
New York (1765)
North Carolina (1112)
North Dakota (8)
Northern California (2660)
Ohio (214)
Oklahoma (15)
Oregon (48)
Pennsylvania (1378)
Puerto Rico (12)
Rhode Island (35)
South America (1652)
South Carolina (23)
South Dakota (1)
Southern California (2307)
Tennessee (104)
Texas (939)
Utah (187)
Virginia (166)
Washington D.C. (69)
Washington State (596)
West Virginia (3)
Wisconsin (66)
There are 845,315 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
SpringWorks Surges on Potential $3.5B Merck KGaA Buyout
The transaction, which sources say could be agreed upon as soon as Monday, would price SpringWorks at $47 per share, totaling approximately $3.5 billion for the acquisition.
April 25, 2025
·
2 min read
·
Tristan Manalac
Legal
Judge Rules Against Semaglutide Compounders After Shortage Ruled Over
Big compounders will have until May 22 to stop producing and dispensing compounded semaglutide, while smaller, state-run pharmacies must immediately stop making copies of the blockbuster drug.
April 25, 2025
·
2 min read
·
Tristan Manalac
Earnings
Gilead’s PrEP Launch Full Speed Ahead, Despite Macro Pressures on HIV Space
Despite steep budget and staffing cuts at the FDA in recent weeks and other headwinds, Gilead CEO Daniel O’Day assured investors that the pharma’s plans and preparations for lenacapavir’s launch remain on track.
April 25, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Solid Tumors
April 25, 2025
·
2 min read
Press Releases
Philips provides update on the Annual General Meeting of Shareholders 2025 Agenda
April 25, 2025
·
2 min read
Press Releases
Avantor® Announces CEO Transition
April 25, 2025
·
4 min read
Press Releases
Avantor® Reports First Quarter 2025 Results
April 25, 2025
·
18 min read
Press Releases
CENTENE CORPORATION REPORTS FIRST QUARTER 2025 RESULTS
April 25, 2025
·
31 min read
Press Releases
InnoCare Announces Approval of Orelabrutinib for the First-line Treatment of CLL/SLL in China
April 25, 2025
·
4 min read
Press Releases
TREMFYA® (guselkumab) receives European Commission approval for adults with moderately to severely active ulcerative colitis, strengthening Johnson & Johnson’s leadership in inflammatory bowel disease
April 25, 2025
·
14 min read
1 of 84,532
Next
